Clinical trial
A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
NCT01231334 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
- Lead sponsor
- Allergan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- June 30, 2011
- Enrollment
- 286 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.